vs
Side-by-side financial comparison of Dexcom (DXCM) and Liberty Energy Inc. (LBRT). Click either name above to swap in a different company.
Dexcom is the larger business by last-quarter revenue ($1.3B vs $1.0B, roughly 1.2× Liberty Energy Inc.). Dexcom runs the higher net margin — 21.2% vs 2.2%, a 19.0% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 4.5%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs -6.2%).
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
Liberty Energy Inc. is a North American energy services provider specializing in hydraulic fracturing and well completion solutions for oil and gas operators. It serves clients across major U.S. shale basins, offering low-emission equipment and tailored support to optimize well productivity.
DXCM vs LBRT — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $1.0B |
| Net Profit | $267.3M | $22.6M |
| Gross Margin | 62.9% | — |
| Operating Margin | 25.6% | 2.2% |
| Net Margin | 21.2% | 2.2% |
| Revenue YoY | 21.6% | 4.5% |
| Net Profit YoY | 153.6% | 64.8% |
| EPS (diluted) | $0.67 | $0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | $1.0B | ||
| Q4 25 | $1.3B | $1.0B | ||
| Q3 25 | $1.2B | $947.4M | ||
| Q2 25 | $1.2B | $1.0B | ||
| Q1 25 | $1.0B | $977.5M | ||
| Q4 24 | $1.1B | $943.6M | ||
| Q3 24 | $994.2M | $1.1B | ||
| Q2 24 | $1.0B | $1.2B |
| Q1 26 | $267.3M | $22.6M | ||
| Q4 25 | $267.3M | $13.7M | ||
| Q3 25 | $283.8M | $43.1M | ||
| Q2 25 | $179.8M | $71.0M | ||
| Q1 25 | $105.4M | $20.1M | ||
| Q4 24 | $151.7M | $51.9M | ||
| Q3 24 | $134.6M | $73.8M | ||
| Q2 24 | $143.5M | $108.4M |
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | 20.6% | ||
| Q3 25 | 60.5% | 18.7% | ||
| Q2 25 | 59.5% | 22.1% | ||
| Q1 25 | 56.9% | 22.1% | ||
| Q4 24 | 58.9% | 21.4% | ||
| Q3 24 | 59.7% | 26.2% | ||
| Q2 24 | 62.4% | 27.9% |
| Q1 26 | 25.6% | 2.2% | ||
| Q4 25 | 25.6% | 1.9% | ||
| Q3 25 | 20.1% | -0.3% | ||
| Q2 25 | 18.4% | 3.6% | ||
| Q1 25 | 12.9% | 1.9% | ||
| Q4 24 | 17.0% | 2.6% | ||
| Q3 24 | 15.3% | 9.4% | ||
| Q2 24 | 15.7% | 12.2% |
| Q1 26 | 21.2% | 2.2% | ||
| Q4 25 | 21.2% | 1.3% | ||
| Q3 25 | 23.5% | 4.5% | ||
| Q2 25 | 15.5% | 6.8% | ||
| Q1 25 | 10.2% | 2.1% | ||
| Q4 24 | 13.6% | 5.5% | ||
| Q3 24 | 13.5% | 6.5% | ||
| Q2 24 | 14.3% | 9.3% |
| Q1 26 | $0.67 | $0.14 | ||
| Q4 25 | $0.67 | $0.08 | ||
| Q3 25 | $0.70 | $0.26 | ||
| Q2 25 | $0.45 | $0.43 | ||
| Q1 25 | $0.27 | $0.12 | ||
| Q4 24 | $0.37 | $0.31 | ||
| Q3 24 | $0.34 | $0.44 | ||
| Q2 24 | $0.35 | $0.64 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $917.7M | $699.1M |
| Total DebtLower is stronger | — | $7.1M |
| Stockholders' EquityBook value | $2.7B | $1.9B |
| Total Assets | $6.3B | $4.4B |
| Debt / EquityLower = less leverage | — | 0.00× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $917.7M | $699.1M | ||
| Q4 25 | $917.7M | $27.6M | ||
| Q3 25 | $1.8B | $13.5M | ||
| Q2 25 | $1.2B | $19.6M | ||
| Q1 25 | $904.9M | $24.1M | ||
| Q4 24 | $606.1M | $20.0M | ||
| Q3 24 | $621.2M | $23.0M | ||
| Q2 24 | $939.2M | $30.0M |
| Q1 26 | — | $7.1M | ||
| Q4 25 | — | $246.6M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $190.5M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $2.7B | $1.9B | ||
| Q4 25 | $2.7B | $2.1B | ||
| Q3 25 | $2.7B | $2.1B | ||
| Q2 25 | $2.6B | $2.0B | ||
| Q1 25 | $2.3B | $2.0B | ||
| Q4 24 | $2.1B | $2.0B | ||
| Q3 24 | $2.0B | $2.0B | ||
| Q2 24 | $2.4B | $1.9B |
| Q1 26 | $6.3B | $4.4B | ||
| Q4 25 | $6.3B | $3.6B | ||
| Q3 25 | $7.5B | $3.5B | ||
| Q2 25 | $7.3B | $3.4B | ||
| Q1 25 | $6.8B | $3.4B | ||
| Q4 24 | $6.5B | $3.3B | ||
| Q3 24 | $6.4B | $3.3B | ||
| Q2 24 | $6.8B | $3.2B |
| Q1 26 | — | 0.00× | ||
| Q4 25 | — | 0.12× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.10× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
